BackIsracann Biosciences Overview

Isracann Biosciences Receivables

Latest receivables for ISCNF: $83K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$83210.00
↓ 14.94% YoYΔ $-14620.00 vs prior year quarter

Peer trimmed avg / median

Loading

Isracann Biosciences Receivables History

Loading

Isracann Biosciences vs. peers: Receivables Comparison

Loading

Isracann Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Isracann Biosciences (ISCNF) FAQ

Isracann Biosciences posts a receivables of $83K as of August 2022. That compares with $98K in the prior-year period — down 14.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Isracann Biosciences's receivables was $98K. The latest reading is $83K — a 14.9% year-over-year decrease (period ending August 2022). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Isracann Biosciences's financial statement story. At $83K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ISCNF's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Isracann Biosciences's other metric pages and overview cover the third.